| top | |
| BRAINLIFE NEWSLETTER | |
Volume 3, Number 23 - 2 July
2004 |
|
|
|
|
|
Contents |
|
|
|
|
| Etiology & Pathogenesis | |
| Overall Management | |
| Treatment | |
|
|
|
|
|
|
|
|
|
|
A. M. Cappellano, M.
T. Grande, S. N. Oliveira, L. J. G. Zambaldi, M. Araujo, F. A.
Freitas, I. A. Cardinalli, S. R. Brandalise, S. S. Aguiar
A novel translocation (x;4)(p22.1;q32) in a child with malignant Schwannoma 40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8572 |
|
|
L. Girard, J. D. Minna, T.
Chen, G. Tomlinson, D. Bowers
Gene expression profiling of progressive and stable childhood pilocytic astrocytomas 40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8546 |
|
|
J. Mora, M. Alaminos, N.-K. Cheung,
J. Rios, W. Gerald
Gene expression profiling of neuroblastoma: Analysis of nonmetastatic versus metastatic tumors 40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8538 |
|
|
|
|
|
|
|
|
|
|
|
E. G. Rivarola, G. L. Chantada, L.
Ezcurdia, A. Negro, E. Gil Deza, D. Cascallar, D. Santillán, S. Carnaval, E.
Morgenfeld, F. G. Gercovich
Adherence to standard therapy for the treatment of childhood CNS tumors in Argentina. An audit perspective 40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8573 |
|
|
|
|
|
|
|
|
|
|
|
A. Batova, A. L. Yu, D. Strother,
P. Angelini, A. Eskenazi
Promising results of a pilot trial of a GD2 directed anti-idiotypic antibody as a vaccine for high risk neuroblastoma 40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8511 |
|
|
G. Biswas, P. Kurkure, S. Banavali,
S. Achrekar, P. Kulkarni, R. Bhagwat, L. Sharma
Challenges in management of advanced neuroblastoma: Experience at Tata Memorial Hospital, Mumbai, India 40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8562 |
|
|
A. Donfrancesco, A. Jenkner, A.
Castellano, I. Ilari, G. M. Milano, C. Dominici, L. De Sio, P. Fidani
Front-line topotecan and high-dose cyclophosphamide followed by ICE in high-risk neuroblastoma 40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8536 |
|
|
C. N. Frantz, W. B. London, L.
Diller, R. Seeger, K. Sawyer
Recurrent neuroblastoma: Randomized treatment with topotecan + cyclophosphamide (T+C) vs. topotecan alone(T). A POG/CCG Intergroup Study 40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8512 |
|
|
C. Laverdiere, N. K. V. Cheung, B.
H. Kushner, K. Kramer, S. Modak, M. P. La Quaglia, S. Wolden, K. K. Ness, J. G.
Gurney, C. A. Sklar
Long term complications from treatment in survivors of high risk neuroblastoma 40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8543 |
|
|
M. M. Meshref, D. Frappaz, C.
Alapetite, J. . Gentet, Y. Perel, M. C. Baranzelli, P. Chastagner, C.
Patte
Bifocal Intracranial germinoma (BIG): Is there a place for localized radiation? 40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8548 |
|
|
R. Morosetti, D. Meco, C. Dominici,
T. Servidei, A. Riccardi, A. M. Di Francesco, G. Cusano, R. Riccardi
Antitumor activity of imatinib mesylate in medulloblastoma cell lines and xenografts 40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8554 |
|
